Iron oxide nanoparticles for therapeutic applications.

Alphandéry E

doi:10.1016/j.drudis.2019.09.020

Back

Journal article

Iron oxide nanoparticles for therapeutic applications.

Alphandéry E Sorbonne Université, Muséum National d'Histoire Naturelle, UMR CNRS 7590, IRD, Institut de Minéralogie, de Physique des Matériaux et de Cosmochimie, IMPMC, Place Jussieu, 75005, Paris, France; Nanobacterie SARL, 36 boulevard Flandrin, 75116, Paris, France; Institute of Anatomy, UZH University of Zurich, Institute of Anatomy, Winterthurerstr. 190, CH-8057, Zurich, Switzerland. Electronic address: edouardalphandery@hotmail.com.

2019-10-07

Published in:

Drug discovery today. - 2020

English In nanomedicine, iron oxide nanoparticles are at an advanced stage, being commercialized for cancer treatment and iron-deficiency anemia treatment. Their therapeutic efficacy comes from their ability to target a tissue, activate a drug, locally produce a temperature increase following (or not) the application of an external source of energy, modify genes or activate various biological materials, or replace diseased cells by stem cells. Owing to these various mechanisms of action, they can potentially be used for treating a whole range of different diseases, making them more appealing than conventional drugs that target a more limited number of indications.

Language